Publications by authors named "Francis J B Kynaston-Pearson"
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Vicente Ruiz Garcia Paresh Jobanputra Amanda Burls Juan B Cabello Paloma Vela Casasempere Francis J B Kynaston-Pearson
Cochrane Database Syst Rev
September 2014
Background: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms of reducing the risk of joint damage, improving physical function and improving quality of life. This Cochrane review is an update of a review of the treatment of RA with certolizumab pegol that was first published in 2011.
Objectives: To assess the clinical benefits and harms of certolizumab pegol (CDP870) in patients with RA who have not responded well to conventional disease-modifying anti-rheumatic drugs (DMARDs).